How We Do It

Guiding Patients Facing Decisions about “Futile” Chemotherapy


 

11 American Society of Clinical Oncology Outcomes Working Group, Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol, 14 (1996), pp. 671–679.

12 Eastern Cooperative Oncology Group, ECOG Performance Status, http://ecog.dfci.harvard.edu/general/perf_stat.html Accessed November 30, 2010.

13 J. Finn, K. Pienta and J. Parzuchowski, Bridging cancer treatment and hospice care. Proc Am Soc Clin Oncol, 21 (2002), p. 1452.

14 G. Gade, I. Venohr, D. Conner, K. McGrady, J. Beane, R.H. Richardson, M.P. Williams, M. Liberson, M. Blum and R. Della Penna, Impact of an inpatient palliative care team: a randomized control trial. J Palliat Med, 11 2 (2008), pp. 180–190.

Copyright © 2011 Elsevier Inc. All rights reserved.


Pages

Recommended Reading

New Nomograms Predict Lymphedema After Axillary Lymph Node Dissection
MDedge Hematology and Oncology
FDA Panel: Update Bisphosphonate Labeling
MDedge Hematology and Oncology
Venlafaxine, Clonidine Top Placebo for Breast Cancer Hot Flashes
MDedge Hematology and Oncology
Arrhythmia Risk Leads to Ondansetron Label Changes
MDedge Hematology and Oncology
Denosumab Approved for Bone Loss From Hormone Ablation Therapy
MDedge Hematology and Oncology
Commentary: Depression Stymies Care in Latina Breast Cancer Survivors
MDedge Hematology and Oncology
Taxane-Induced Neuropathy Gives No Clue to Breast Cancer Outcomes
MDedge Hematology and Oncology
Ibandronate Relieves Metastatic Prostate Cancer Bone Pain
MDedge Hematology and Oncology
ASCO Updates Guidelines on Antiemetics in Oncology
MDedge Hematology and Oncology
Understanding Bereavement: What Every Oncology Practitioner Should Know
MDedge Hematology and Oncology